Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4. This reflects a minor metadata update to the document without changes to visible content.SummaryDifference0.0%

- Check28 days agoChange DetectedA new publication citation has been added under Publications describing a study on ENVISION trial data related to the investigational agent and IgA nephropathy; it indicates ongoing dissemination of related research.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3. This indicates a newer version of the study documentation associated with the page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now indicates recruitment is closed with 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and records the latest Revision: v3.6.0 document.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page or its documentation rather than substantive changes to the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedA new revision entry v3.5.4 has been added and the previous revision v3.5.3 has been removed, indicating an update to the documented revision history.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.